1. Home
  2. BPMC vs ESI Comparison

BPMC vs ESI Comparison

Compare BPMC & ESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • ESI
  • Stock Information
  • Founded
  • BPMC 2008
  • ESI 1922
  • Country
  • BPMC United States
  • ESI United States
  • Employees
  • BPMC N/A
  • ESI N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • ESI Major Chemicals
  • Sector
  • BPMC Health Care
  • ESI Industrials
  • Exchange
  • BPMC Nasdaq
  • ESI Nasdaq
  • Market Cap
  • BPMC 5.8B
  • ESI 6.3B
  • IPO Year
  • BPMC 2015
  • ESI N/A
  • Fundamental
  • Price
  • BPMC $99.18
  • ESI $21.16
  • Analyst Decision
  • BPMC Buy
  • ESI Strong Buy
  • Analyst Count
  • BPMC 21
  • ESI 9
  • Target Price
  • BPMC $124.05
  • ESI $26.89
  • AVG Volume (30 Days)
  • BPMC 1.0M
  • ESI 3.2M
  • Earning Date
  • BPMC 05-01-2025
  • ESI 04-23-2025
  • Dividend Yield
  • BPMC N/A
  • ESI 1.50%
  • EPS Growth
  • BPMC N/A
  • ESI 118.34
  • EPS
  • BPMC N/A
  • ESI 1.18
  • Revenue
  • BPMC $562,121,000.00
  • ESI $2,475,600,000.00
  • Revenue This Year
  • BPMC $44.85
  • ESI N/A
  • Revenue Next Year
  • BPMC $32.06
  • ESI $4.57
  • P/E Ratio
  • BPMC N/A
  • ESI $18.14
  • Revenue Growth
  • BPMC 99.19
  • ESI 6.08
  • 52 Week Low
  • BPMC $73.04
  • ESI $16.77
  • 52 Week High
  • BPMC $121.90
  • ESI $29.78
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 65.95
  • ESI 54.85
  • Support Level
  • BPMC $97.91
  • ESI $20.50
  • Resistance Level
  • BPMC $104.86
  • ESI $21.47
  • Average True Range (ATR)
  • BPMC 3.74
  • ESI 0.61
  • MACD
  • BPMC 1.50
  • ESI 0.37
  • Stochastic Oscillator
  • BPMC 83.26
  • ESI 96.21

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company has two segments which are Electronics and Industrial & Specialty. The Industrial & Specialty segment which generates majority of the revenue, includes chemical systems that protect and decorate metal and plastic surfaces; consumable chemicals that enable printing image transfer on flexible packaging materials; and chemistries used in water-based hydraulic control fluids in offshore energy production. Electronics segment researches, formulates and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging.

Share on Social Networks: